For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Alector LLC

USPTO Granted Patents = 48

EPO Patents = 5

Trademarks = 8

Forward Citations = 68

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Arnon Rosenthal (47 out of 120 patents)

Tina Schwabe (22 out of 22 patents)

Seung-Joo Lee (18 out of 18 patents)

4. Helen Lam (13 out of 13 patents)

5. Robert Pejchal (11 out of 12 patents)

6. Patricia Culp (11 out of 13 patents)

7. Michael Kurnellas (9 out of 9 patents)

8. Kate Monroe (9 out of 9 patents)

9. Andrew Pincetic (8 out of 8 patents)

10. Herve Rhinn (8 out of 8 patents)

11. Ilaria Tassi (8 out of 8 patents)

12. Anthony B Cooper (7 out of 9 patents)

13. Francesca Avogadri-Connors (7 out of 7 patents)

14. Angie Grace Yee (7 out of 7 patents)

15. Wei-Hsien Ho (6 out of 26 patents)

Core Competencies:

Anti-Sortilin Antibodies

Anti-MS4A4A Antibodies

Anti-TMEM106B Antibodies

Anti-Siglec-5 Antibodies

Anti-SIRPα Antibodies

Anti-CD33 Antibodies

Anti-Siglec-7 Antibodies

Anti-TREM1 Antibodies

Anti-TREM2 Antibodies

Transgenic Mice

Chimeric Receptors

Sortilin Binding Antagonists

48 patents: Sort by Forward Citations

1. 12358991 - Anti-Sortilin antibodies and methods of use thereof (2025-07-15),

2. 12331112 - Anti-MS4A4A antibodies and methods of use thereof (2025-06-17),

3. 12331111 - Anti-MS4A4A antibodies and methods of use thereof (2025-06-17),

4. 12319734 - Anti-TMEM106B antibodies and methods of use thereof (2025-06-03),

5. 12297277 - Anti-sortilin antibodies and methods of use thereof (2025-05-13),

6. 12258410 - Anti-SIRPα antibodies and methods of use thereof (2025-03-25),

7. 12258398 - Anti-Siglec-5 antibodies and methods of use thereof (2025-03-25),

8. 12247073 - Anti-CD33 antibodies and methods of use thereof (2025-03-11),

9. 12227568 - Anti-Siglec-7 antibodies and methods of use thereof (2025-02-18),

10. 12226482 - Anti-SIRP-alpha antibodies and methods of use thereof (2025-02-18),

11. 12215149 - Anti-MS4A6A antibodies and methods of use thereof (2025-02-04),

12. 12186409 - Methods of screening for sortilin binding antagonists (2025-01-07),

13. 12110327 - Anti-TREM1 antibodies and methods of use thereof (2024-10-08),

14. 12060422 - Anti-SIRP-Beta1 antibodies and methods of use thereof (2024-08-13),

15. 12004494 - Siglec transgenic mice and methods of use thereof (2024-06-11),

Alector is a clinical-stage biotechnology company that focuses on developing immuno-neurology therapies for neurodegenerative diseases. They are committed to pioneering a new approach to treating Alzheimer's disease, frontotemporal dementia, and other forms of dementia. With a unique understanding of the immune system's role in neurodegenerative disorders, Alector aims to harness the power of the immune system to slow down or halt the progression of these diseases. Through their innovative research and collaboration with academic institutions, they strive to make a lasting impact on patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

48 Patents

#32 in South San Francisco, CA

#1,667 in California

#7,025 in US

#14,122 in the World

South San Francisco, CA, United States of America

Alector LLC

Forward Citations = 68

37 inventors:

Arnon Rosenthal (47 out of 120 patents)

Tina Schwabe (22 out of 22 patents)

Seung-Joo Lee (18 out of 18 patents)

4. Helen Lam (13 out of 13 patents)

5. Robert Pejchal (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…